Symbiosis Pharma Private Limited

What Symbiosis Pharma Private Limited does

Symbiosis Pharma Private Limited is an India-based pharmaceutical manufacturer founded in 2006 and headquartered in Kala Amb, Himachal Pradesh. The company operates across 14 divisions and subsidiaries covering general pharmaceuticals, nutraceuticals, Ayurvedic formulations and sports nutrition, manufacturing from a WHO-GMP certified facility built to ISPE design standards. Its commercial reach spans 11 countries across CIS, the Baltic States, Central Asia, Southeast Asia, Asia Pacific and Africa.

The company generates revenue through three distinct channels: a domestic PCD (Propaganda Cum Distribution) franchise network, third-party/contract manufacturing services for other pharmaceutical brands, and direct exports to international markets. Group-level revenue is reported at approximately Rs. 1,000 crore, placing the business in the mid-market Indian pharma segment. The PCD franchise channel targets India's long-tail distributor base; the contract manufacturing channel monetises certified capacity with external brand owners; and the export channel serves overseas distributors and, potentially, institutional buyers across the listed geographies. No named customers, key account dependencies, or contract-level disclosures were identified in the available material.

Operationally, Symbiosis relies on conventional pharmaceutical manufacturing rather than technology-led differentiation. The company does not disclose proprietary platforms, AI/ML systems, or digital health products, and its competitive positioning rests on regulatory credentials (WHO-GMP, ISPE-aligned facilities), multi-channel distribution, and the breadth of its 14-division brand portfolio. The combination of franchise, contract manufacturing and export provides revenue diversification across customer types and geographies, while also exposing the business to the typical risks of fragmented domestic distribution and regulatory variance across export markets.

Name

Symbiosis Pharma Private Limited

Legal name

Symbiosis Pharma Pvt Ltd

Website

https://symbiosispharma.in

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Symbiosis Pharma Private Limited is an Indian pharmaceutical manufacturer founded in 2006, operating 14 divisions across general pharma, nutraceuticals and Ayurveda from its WHO-GMP certified Kala Amb facility, serving domestic franchisees, contract manufacturing clients and export markets across 11 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical manufacturing
• Third party manufacturing
• PCD franchise distribution
• Nutraceutical products
• Generic pharmaceutical export

Headquarters

HQ city

Kala Amb

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. PCD Franchise: Propaganda Cum Distribution franchise model where franchise partners market and distribute pharmaceutical products under their own brand in assigned territories. Revenue generated from product supply to franchise partners.
2. Third Party Manufacturing: Contract manufacturing services for other pharmaceutical companies who provide formulations and receive finished products for their brand distribution.
3. Pharmaceutical Export: Direct export of pharmaceutical products to international markets across CIS, Baltic States, Central Asia, South East Asia, Asia Pacific, and African Continent.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Symbiosis Pharma is a diversified pharmaceutical manufacturer founded in 2006 that produces formulations across Pharmaceuticals, Nutraceuticals, Ayurveda, and Sports Nutrition segments through 14 divisions. The company operates three primary commercial channels: PCD (Propaganda Cum Distribution) franchise partnerships for domestic Indian distribution, third-party/contract manufacturing for other pharmaceutical companies, and direct export of generic pharmaceutical products to international markets across CIS, Baltic States, Central Asia, South East Asia, Asia Pacific, and Africa.

Product overview

Symbiosis Pharma Private Limited is a diversified pharmaceutical group founded in 2006 with operations spanning Pharmaceuticals, Nutraceuticals, Ayurveda, and Sports Nutrition segments. The company operates through 14 distinct divisions (Elder Life Sciences, Coastal Healthcare, Materkin Formulations, Ovation, Polard Healthcare, Polaris Healthcare, Saitech Medicare, Seagate Biosciences, Stadchem LifeSciences, Symbiosis Biosciences, Symbiosis Healthcare, Symbiosis Lifecare, Yellowstone Bioceuticals, and the core Symbiosis Pharma brand), each specializing in different therapeutic categories and formulations. The group provides end-to-end solutions from research to market launch, with three main brand categories: Symbiosis Ayurveda for holistic health solutions, Symbiosis Drugs for pharmaceutical products, and Symbiosis Nutraceuticals for dietary supplements. Product portfolio includes tablets across antibiotics, cardiovascular, pain management, neurological, gastrointestinal, and nutritional supplement categories. The company also offers PCD franchise, third-party manufacturing, and export services across 11 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Symbiosis Ayurveda: Holistic health and personal care solutions
• Symbiosis Drugs
• Symbiosis Nutraceuticals
• Omega-3+ D3

Products and services

• PCD Franchise Program A Propaganda Cum Distribution (PCD) franchise program offering business opportunities to entrepreneurs and distributors across India for marketing and distributing pharmaceutical products under their own brand with assigned territorial rights.
• Third Party Manufacturing Services Contract manufacturing services for pharmaceutical companies requiring production of branded formulations and finished dosage forms, delivered through WHO-GMP approved facilities.
• International Pharmaceutical Export Services Direct export of generic pharmaceutical products to international markets across CIS, Baltic States, Central Asia, South East Asia, Asia Pacific, and African Continent through a dedicated export team.
• Omega-3+ D3 Fish oil softgel supplement providing 600mg fish oil and 400 IU Vitamin D3 per capsule, supporting cardiovascular health, brain and eye development, and bone health.
• Symbiosis Ayurveda Brand line offering holistic health and personal care solutions combining traditional Ayurvedic formulations with modern pharmaceutical standards.
• Symbiosis Drugs Brand line providing end-to-end pharmaceutical solutions from research to market launch, covering the complete drug development and commercialization lifecycle across multiple therapeutic categories.
• Symbiosis Nutraceuticals Brand line offering innovative, research-driven nutraceutical solutions for dietary supplementation and wellness.

Quantifiable outcome

• Rs.1000 Cr revenue (approx. 160 Million USD)
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• CPHI (Various Years)coreOthersParticipation in CPHI (Convention on Pharmaceutical Ingredients) trade shows including CPHI Dubai for international pharmaceutical networking, business development, and market expansion activities.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ipca Laboratories: Indian API and finished dosage form manufacturer with strong export orientation and contract manufacturing. Comparable as a mid-sized Indian formulations/API player with international footprint.
• Ajanta Pharma: Indian specialty generic formulations manufacturer with strong branded generics presence in India and emerging market exports. Comparable therapeutic breadth and emerging-market export orientation.
• Alkem Laboratories: Indian pharmaceutical manufacturer with multi-therapeutic formulation portfolio, domestic and international operations, and contract manufacturing capabilities. Comparable in scale, manufacturing breadth, and export orientation to Symbiosis.
• Morepen Laboratories: Indian pharmaceutical manufacturer focused on APIs, formulations, and OTC/home diagnostics with PCD distribution. Similar mid-scale manufacturing and franchise-driven distribution profile.
• Mankind Pharma: Large Indian generic pharma company with a strong PCD franchise distribution model and domestic prescription/OTC portfolio. Highly comparable business model, customer segments (franchise partners, distributors), and therapeutic breadth to Symbiosis.

Broad incumbents

• Torrent Pharmaceuticals: Large Indian pharmaceutical company with branded generics, chronic therapy portfolio, and international operations. Comparable across the formulations manufacturing and export-led growth profile.
• Emami: Indian FMCG and Ayurvedic personal care/health company. Comparable via Symbiosis Ayurveda and Symbiosis Nutraceuticals segments, particularly for wellness and traditional-medicine consumer positioning.
• Glenmark Pharmaceuticals: Indian-headquartered pharmaceutical company with global generics, specialty, and API businesses across emerging markets. Comparable for the international export orientation and multi-therapeutic formulation portfolio.
• Dabur India: Largest Indian Ayurvedic and natural health products company with international presence. Comparable across Ayurveda, nutraceuticals, and the OTC consumer health segments Symbiosis targets.
• TTK Healthcare: Diversified Indian healthcare company spanning pharmaceuticals, consumer health, and OTC. Comparable across the pharma + nutraceutical/consumer health mix that Symbiosis operates through its divisions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/symbiosis-pharma-private-limited

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symbiosis Pharma Private Limited